In a bold leap forward for cardiac surgery, Nordson Medical—a global leader in cardiac perfusion technology—has dedicated over three decades to redefining myocardial protection. Their mission is simple yet critical: to empower the cardiac surgical team with precise, safe and customizable solutions that greatly improve patient outcomes.

Nordson Medical developed the Myocardial Protection System (MPS) as its next-generation platform for myocardial protection, building on its legacy MPS technology and long-standing expertise in cardiac perfusion. HCLTech partnered with Nordson Medical to support development across key engineering disciplines. Fully programmable and compliant with global safety standards, the MPS combines flexibility with clinical precision to redefine surgical safety.

Developed by Nordson Medical with engineering support from HCLTech’s team in India, the MPS represents a significant advancement in myocardial protection for cardiac surgery.

As cardiovascular disease continues to rise—driven by aging populations, sedentary lifestyles and increasing comorbidities—cardiac surgeries such as Coronary Artery Bypass Grafting (CABG) are becoming more challenging and complex. These high-risk procedures demand exceptional precision, adaptability and real-time control to ensure patient safety.

Traditional cardioplegia systems, however, are constrained by outdated technology and manual limitations, making them inadequate for today’s evolving surgical needs. Recognizing this gap, Nordson Medical initiated the development of a next-generation solution to bring greater intelligence, reliability and clinical adaptability into the cardiac operating room, partnering with HCLTech to support execution.

Nordson Medical’s vision was not to build another device, but to advance myocardial protection through a next-generation system that improves precision, automation and workflow integration.

The Nordson Medical MPS platform was designed to:

From rapid cold-start readiness to clinician-friendly usability, the system was engineered for high-stakes environments where safety and accuracy are non-negotiable. Developed in compliance with FDA QSR, CE and ISO 13485 standards, the MPS ensures full traceability, uncompromised safety and reliable outcomes.

This is not just incremental innovation—it is a transformation in how cardiac care is delivered.

Working in partnership with Nordson Medical, HCLTech’s Engineering and R&D Services team in Chennai supported the development of a digitally intelligent platform designed to enhance safety, accuracy and efficiency in cardiac surgery.

As part of the development partnership, Nordson Medical and HCLTech worked across software, controls, fluidics and usability to strengthen the MPS platform.

Key highlights

Enhanced usability and integration

HCLTech served as a development partner to Nordson Medical, contributing engineering expertise and scalable support across multiple phases of the MPS program.

From concept to development, the Myocardial Protection System reflects Nordson Medical’s continued leadership in myocardial protection. Developed by Nordson Medical with significant engineering support from HCLTech, it stands today as a trusted solution deployed across global healthcare systems.

Supported by global engineering collaboration and trusted worldwide: A milestone in MedTech engineering that highlights the value of strong development partnerships in healthcare innovation.

Key achievements

In close collaboration with our clients, we continue to push the boundaries of digital healthcare—from AI and IoMT-enabled diagnostics to surgical robotics and smart materials. With each innovation, we move closer to a smarter, safer and healthier future for patients worldwide.